OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	168
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	85
Conflict and Access to Health Care	53
Managing First-Line Metastatic Renal Cell Carcinoma	43
Copyright	42
Forthcoming Issues	41
Contemporary Management of Dermatofibrosarcoma Protuberans	41
Remote Telemonitoring and Telehealth in Surgical Oncology	39
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	38
Contents	37
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	37
Treatment of High-Risk Gestational Trophoblastic Neoplasia	34
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	34
Benefits and Harms of Interception and Early Detection of Cancer	30
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	29
Advances in Gastric Cancer Surgical Management	21
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	20
Hematology/Oncology Clinics of North America	19
Contents	18
Contributors	18
Contributors	17
Copyright	17
Disparities in Breast Cancer Outcomes and How to Resolve Them	16
The Landscape of Personalized Medicine in Gynecologic Cancer	16
Future Directions for Gestational Trophoblastic Disease	15

Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	15
Histiocytic Disorders in Pediatric and Adult Patients	14
Contents	14
Advances in Systemic Therapy in Pancreatic Cancer	14
Advances in Immunotherapy in Esophagogastric Cancer	14
Liposarcoma	14
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	13
Genomic Alterations in Langerhans Cell Histiocytosis	13
Emerging Therapies in β-Thalassemia	13
Copyright	13
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	13
Advances in Surgical Techniques for Lung Cancer	13
Clinical Vignettes Part I	13
Foreword	13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	13
Forthcoming Issues	12
Skin Cancer Precursors	12
Hereditary Renal Cell Carcinoma Syndromes	11
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer	11
Malignancies of the Upper Gastrointestinal Tract	11
Genes as Medicine	11
The Evolving Role of Surgery in Multimodal Cancer Care	11
Evaluation and Management of Bing–Neel Syndrome	11
Forthcoming Issues	11
Advances in the Surgical Management of Esophageal Cancer	10
Patient-Reported Outcomes in Radiation Oncology	10
Local Control in Soft Tissue Sarcomas	10
Gestational Trophoblastic Neoplasia	10
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	10
Copyright	10
Management of In-Transit Metastatic Melanoma	10
New Developments in Myeloma	9
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	9
Contents	9
Forthcoming Issues	8
Evolution of Gene Therapy, Historical Perspective	8
Bispecific Antibodies in the Treatment of Multiple Myeloma	8
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	8
Forthcoming Issues	8
High-Risk Non-Melanoma Skin Cancers	8
Contributors	8
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?	8
Copyright	7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	7
Breast Cancer in India	7
Clinical Complications and Their Management	7
Contents	7
Copyright	7
Melanoma Brain Metastasis	7
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	7

Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	7
Contents	7
Breast Cancer and Lifestyle Factors	7
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	7
Radiation-Induced Tissue Regeneration	7
Contributors	6
Copyright	6
Hemophilia A/B	6
Surgery for Recurrent Ovarian Cancer	6
FLASH Radiotherapy	6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	6
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	6
Impact of Clonal Heterogeneity in Multiple Myeloma	6
Pathogenic Mechanisms in Thalassemia II	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
Education and Training Models for Remote Learning	6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	6
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Early-Stage Hodgkin Lymphoma	6
Ductal Carcinoma In Situ	6
Targeted Therapy Innovations for Melanoma	6
Contents	5
Debate	5
Contents	5
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia	5
Genetics and Genomics of Gestational Trophoblastic Disease	5
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	5
Sarcomas	5
Immune-Pathogenesis of Myeloma	5
Advances in Cervical Cancer	5
Renal Cell Cancer	5
Regulatory Aspects of Gene Therapy	5
Role of Radiation in Treatment of Renal Cell Carcinoma	5
Contents	5
Forthcoming Issues	5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	5
Early Detection of Precursor Diseases of Multiple Myeloma	5
Pathogenic Mechanisms in Thalassemia I	5
Contributors	5
Remembering the Contributions of Professor David J. Weatherall	5
Waldenström Macroglobulinemia	5
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)	5
Approach to High-Risk Multiple Myeloma	5
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	5
Merkel Cell Carcinoma	5
Local Therapies in Advanced Colorectal Cancer	5
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	5